HUE042886T2 - Mesterséges baktérium kromoszómák - Google Patents

Mesterséges baktérium kromoszómák

Info

Publication number
HUE042886T2
HUE042886T2 HUE14724009A HUE14724009A HUE042886T2 HU E042886 T2 HUE042886 T2 HU E042886T2 HU E14724009 A HUE14724009 A HU E14724009A HU E14724009 A HUE14724009 A HU E14724009A HU E042886 T2 HUE042886 T2 HU E042886T2
Authority
HU
Hungary
Prior art keywords
bacterial chromosomes
artificial bacterial
artificial
chromosomes
bacterial
Prior art date
Application number
HUE14724009A
Other languages
English (en)
Hungarian (hu)
Inventor
Kai Dallmeier
Johan Neyts
Original Assignee
Univ Leuven Kath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leuven Kath filed Critical Univ Leuven Kath
Publication of HUE042886T2 publication Critical patent/HUE042886T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
HUE14724009A 2013-04-26 2014-04-25 Mesterséges baktérium kromoszómák HUE042886T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1307528.8A GB201307528D0 (en) 2013-04-26 2013-04-26 Bacterial artificial chromosomes

Publications (1)

Publication Number Publication Date
HUE042886T2 true HUE042886T2 (hu) 2019-07-29

Family

ID=48626864

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14724009A HUE042886T2 (hu) 2013-04-26 2014-04-25 Mesterséges baktérium kromoszómák

Country Status (17)

Country Link
US (2) US10076564B2 (enExample)
EP (2) EP3540065A1 (enExample)
JP (1) JP6501756B2 (enExample)
KR (1) KR102170609B1 (enExample)
CN (2) CN105229153A (enExample)
AU (1) AU2014259354B2 (enExample)
BR (1) BR112015026531B1 (enExample)
DK (1) DK2989205T3 (enExample)
ES (1) ES2718187T3 (enExample)
GB (1) GB201307528D0 (enExample)
HU (1) HUE042886T2 (enExample)
PL (1) PL2989205T3 (enExample)
PT (1) PT2989205T (enExample)
SI (1) SI2989205T1 (enExample)
TR (1) TR201904215T4 (enExample)
WO (1) WO2014174078A1 (enExample)
ZA (1) ZA201507795B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201716307D0 (en) 2017-10-05 2017-11-22 Univ Leuven Kath Chimeric yellow fever zika virus strain
GB201716254D0 (en) * 2017-10-05 2017-11-22 Univ Leuven Kath Live-attenuated flaviruses with heterologous antigens
WO2019204654A1 (en) * 2018-04-18 2019-10-24 Utah State University Compositions and methods for zika virus characterization and vaccine development
GB201814563D0 (en) 2018-09-07 2018-10-24 Univ Leuven Kath Chimeric flavivirus lyssavirus vaccines
AU2020273263A1 (en) 2019-04-10 2021-12-02 Katholieke Universiteit Leuven Chimeric Zika-Japanese encephalitis virus
WO2021048003A1 (en) 2019-09-13 2021-03-18 Katholieke Universiteit Leuven Chimeric filovirus vaccines
BR112022004378A2 (pt) 2019-09-13 2022-06-07 Univ Leuven Kath Vacinas para vírus lassa
AU2020353279B2 (en) * 2019-09-25 2025-12-18 Katholieke Universiteit Leuven Large vectors and methods for high-yield production
WO2021170869A1 (en) 2020-02-27 2021-09-02 Katholieke Universiteit Leuven Coronavirus vaccines
EP4743477A1 (en) * 2023-07-11 2026-05-20 ViroVet NV Vectors Expressing an Attenuated RNA Virus of the Arteriviridae Family and Their Uses
WO2025171062A1 (en) * 2024-02-06 2025-08-14 The Regents Of The University Of California iMODULON GENE CLUSTERS AND METHODS TO IDENTIFY AND USE SAME

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665600A (en) 1991-09-18 1997-09-09 Research Corporation Technologies, Inc. Pichia pastoris linear plasmids and DNA fragments thereof
US5866404A (en) 1995-12-06 1999-02-02 Yale University Yeast-bacteria shuttle vector
US6962708B1 (en) 1997-02-28 2005-11-08 Acambis, Inc. Chimeric flavivirus vaccines
US5874259A (en) * 1997-11-21 1999-02-23 Wisconsin Alumni Research Foundation Conditionally amplifiable BAC vector
EP1153136A2 (en) 1998-12-09 2001-11-14 The General Hospital Corporation Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
ES2170622B1 (es) 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
GB2372991B (en) * 2001-03-09 2004-11-17 Fiocruz Fundacao Oswaldo Cruz Flavivirus expression vector
US6472177B1 (en) 2001-04-23 2002-10-29 Wisconsin Alumni Research Foundation Expression vector with dual control of replication and transcription
US6864087B2 (en) * 2001-07-31 2005-03-08 Wisconsin Alumni Research Foundation Method for converting single-copy BAC vectors to conditional high-copy pBAC/oriHC vectors
US20050106733A1 (en) 2001-12-25 2005-05-19 Kenzo Takada Double-stranded cyclic dna capable of proliferating as a bacterial e coli chromosome
WO2004033633A2 (en) 2002-10-04 2004-04-22 Embiosis Pharmaceuticals Compatible host/vector systems for expression of dna
US20070036827A1 (en) 2003-10-29 2007-02-15 The University Of Queensland West nile virus vaccine
US20050214838A1 (en) 2004-03-10 2005-09-29 Waclaw Szybalski Methods for mapping and sequencing nucleic acids
WO2009053988A1 (en) 2007-10-25 2009-04-30 Ramot At Tel-Aviv University Ltd. Production of bac vectors carrying viral genomes
CN101864442A (zh) 2010-05-19 2010-10-20 江苏省农业科学院 重组火鸡疱疹病毒细菌人工染色体转移载体

Also Published As

Publication number Publication date
ZA201507795B (en) 2019-07-31
BR112015026531A2 (enExample) 2017-09-05
SI2989205T1 (sl) 2019-05-31
BR112015026531B1 (pt) 2023-02-07
JP6501756B2 (ja) 2019-04-17
PL2989205T3 (pl) 2019-06-28
DK2989205T3 (en) 2019-04-23
WO2014174078A1 (en) 2014-10-30
TR201904215T4 (tr) 2019-04-22
US20160206723A1 (en) 2016-07-21
EP3540065A1 (en) 2019-09-18
GB201307528D0 (en) 2013-06-12
US20190111125A1 (en) 2019-04-18
ES2718187T3 (es) 2019-06-28
CN120249337A (zh) 2025-07-04
EP2989205B1 (en) 2019-01-02
US10076564B2 (en) 2018-09-18
AU2014259354B2 (en) 2020-02-27
AU2014259354A1 (en) 2015-11-05
KR102170609B1 (ko) 2020-10-28
EP2989205A1 (en) 2016-03-02
JP2016518132A (ja) 2016-06-23
CN105229153A (zh) 2016-01-06
KR20160003032A (ko) 2016-01-08
PT2989205T (pt) 2019-04-23

Similar Documents

Publication Publication Date Title
DK3048874T3 (da) Haploid embryogenese
EP2967969C0 (en) IMPLANT
DK2986722T3 (da) Manipulerede phenylalaninammoniak-lyasepolypeptider
EP2964120A4 (en) ILIAKALVERBINDER
HUE040732T2 (hu) Rhizomania-rezisztens gén
ZA201507795B (en) Bacterial artificial chromosomes
EP2972725A4 (en) SURVIVOR FACES
DK2943561T3 (da) Fotobioreaktor
EP3037112A4 (en) PROSTHESIS
EP2959219A4 (en) Class 1 compliant lens assembly
DE102013106534B8 (de) Chromatographiepipettenspitze
DK3054704T3 (da) Høreapparat
EP2969728C0 (en) HANDLE-POWERED VELOCIPEDE
EP3000858A4 (en) Gellant
ME03083B (me) Veštački sfinkter
EP2970860A4 (en) Genetically modified bacteria
FR3009951B1 (fr) Prothese intra-laryngee
FR3008884B1 (fr) Prothese implantable
ES1078888Y (es) Sosten modular
DK3250754T3 (da) Kunstigt hybridgræs
FI10737U1 (fi) Matemaattiset opetusvälineet
ITMI20130640A1 (it) Protesi per ernioplastica
UA26639S (uk) Штучна шкіра
CO6980135A1 (es) Implante hibrido natural
TH1501001770A (th) การทรีทชีวมวล